Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FJX34
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,000
Award facts
- Contract value 100% obligated
- $25,000.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $25,000 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials, a biosimilar medication used in the treatment of inflammatory conditions. Issued on September 12, 2025, this firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award represents a non-set-aside competitive procurement, demonstrating the contractor's continued capability to meet federal pharmaceutical supply requirements through open competition.
This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains extensive contract awards with the Defense Logistics Agency's Medical Supply Chain, servicing military and veteran healthcare systems with brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJX34?
SPE2DB25FJX34 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FJX34 worth?
The government has obligated $25,000 on SPE2DB25FJX34.
Is contract SPE2DB25FJX34 an order under another contract?
Yes. SPE2DB25FJX34 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJX34 competed?
The extent of competition for SPE2DB25FJX34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award